Evidence mapPaperPMID 40864786Full record

ReviewCurrent issues in molecular biology2025

Oxytocin, Vasopressin and Stress: A Hormetic Perspective.

Hans P Nazarloo, Marcy A Kingsbury, Hannah Lamont, Caitlin V Dale, Parmida Nazarloo, John M Davis, Eric C Porges, Steven P Cuffe, C Sue Carter

Erratum issuedAbstract readReview
In one paragraph

Review in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Hans P NazarlooDepartment of Psychiatry, College of Medicine-Jacksonville, University of Florida, 580 West 8th St., Tower II, 6th Floor, Jacksonville, FL 32209, USA.
Marcy A KingsburyLurie Center for Autism, Mass General Research Institute, Harvard Medical School, Charlestown, MA 02129, USA.
Hannah LamontLurie Center for Autism, Mass General Research Institute, Harvard Medical School, Charlestown, MA 02129, USA.
Caitlin V DaleDedman College of Humanities and Sciences, Southern Methodist University, Dallas, TX 75205, USA.
Parmida NazarlooTraumatic Stress Research Consortium, Kinsey Institute, Indiana University, Bloomington, IN 47405, USA.
John M DavisDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL 60607, USA.ORCID 0000-0003-3963-1654
Eric C PorgesDepartment of Clinical and Health Psychology, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32611, USA.
Steven P CuffeDepartment of Psychiatry, College of Medicine-Jacksonville, University of Florida, 580 West 8th St., Tower II, 6th Floor, Jacksonville, FL 32209, USA.
C Sue CarterDepartment of Psychiatry, College of Medicine-Jacksonville, University of Florida, 580 West 8th St., Tower II, 6th Floor, Jacksonville, FL 32209, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this article is to examine a previously unrecognized role for the vasopressin-oxytocin (VP-OT) system in mammalian "stress-response hormesis." The current review adds hormesis to the long list of beneficial effects of OT. Hormesis, a biphasic adaptive response to low-level stressors, is introduced here to contextualize the dynamic roles of oxytocin and vasopressin. As with hormesis, the properties of the VP-OT system are context-, time-, and dose-sensitive. Here we suggest that one key to understanding hormesis is the fact that VP and OT and their receptors function as an integrated system. The VP-OT system is capable of changing and adapting to challenges over time, including challenges necessary for survival, reproduction and sociality. Prior research suggests that many beneficial effects of OT are most apparent only following stressful experiences, possibly reflecting interactions with VP, its receptors and other components of the hypothalamic-pituitary-adrenal axis. The release of OT is documented following various kinds of hormetic experiences such as birth, vigorous exercise, ischemic events and the ingestion of emetics, including psychedelics. The phasic or cyclic modulation of VP and related "stress" hormones, accompanied or followed by the release of OT, creates conditions that conform to the core principles of hormesis. This concept is reviewed here in the context of other hormones including corticotropin releasing hormone (CRH) and urocortin, as well as cytokines. In general, VP and classic "stress hormones" support an active response, helping to quickly mobilize body systems. OT interacts with all of these, and may subsequently re-establish homeostasis and precondition the organism to deal with future stressors. However, the individual history of an organism, including epigenetic modifications of classical stress hormones such as VP, can moderate the effects of OT. Oxytocin's effects also help to explain the important role of sociality in mammalian resilience and longevity. A hormetic perspective, focusing on a dynamic VP-OT system, offers new insights into emotional and physical disorders, especially those associated with the management of chronic stress, and helps us to understand the healing power of social behavior and perceived safety.

Indexed as

hormesisoxytocinsocialitystressvasopressin

Identifiers

PMID40864786
PMCPMC12384123

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.